Recombinant Human TPI1 Protein，His

TPI1 (Triosephosphate Isomerase 1) is an essential enzyme involved in the glycolytic and gluconeogenic pathways, catalyzing the interconversion between dihydroxyacetone phosphate and glyceraldehyde-3-phosphate. This enzyme plays a critical role in cellular metabolism and energy production, making it pivotal for maintaining glucose homeostasis. Mutations in the TPI1 gene can lead to TPI deficiency, a rare autosomal recessive disorder characterized by severe neurological complications and hemolytic anemia. Given its fundamental biological functions, TPI1 has garnered significant interest for research focused on metabolic diseases and potential therapeutic applications. The production of recombinant TPI1 protein allows for in-depth studies of its enzymatic properties, structural characteristics, and interactions with other biomolecules. Furthermore, recombinant TPI1 can be used to explore the effects of specific mutations on enzyme activity and stability, providing insights into the molecular mechanisms underlying TPI deficiency. These studies not only enhance our understanding of TPI1 and its dysfunction but also pave the way for developing targeted therapies that could alleviate symptoms associated with TPI deficiency and related metabolic disorders. Overall, the investigation of TPI1 as a recombinant protein holds substantial promise in elucidating both basic metabolic processes and potential clinical applications in managing metabolic diseases.